Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST: Fetal Atrial Flutter & SVT Therapy
NCT02624765Phase 3Completed
- Sponsor
- Edgar Jaeggi
- Start
- Feb 2016
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of digoxin, sotalol, flecainide in atrial flutter (AFL), supraventricular tachycardia (SVT), sponsored by Edgar Jaeggi. Started Feb 2016; status: completed.
02
Drugs
digoxinsotalolflecainide
03
Conditions
atrial flutter (AFL)supraventricular tachycardia (SVT)
Beyond the preview
Go deeper on NCT02624765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624765.